(Total Views: 718)
Posted On: 05/21/2020 11:02:27 AM
Post# of 153933
CytoDyn has added the following link on their website (I don't believe this was posted even yesterday):
https://www.genengnews.com/covid-19-candidates/cytodyn/
https://www.cytodyn.com/investors/news-events/in-the-news
I think CytoDyn added this above link, not only because it's fairly comprehensive in a summarized concise manner of recent events/news about the company but because at the bottom it states:
So when you click on the "Front Runner" category, there are 19 out of 200 candidates and counting to address Covid-19:
https://www.genengnews.com/category/covid-19-...nt-runner/
And of course, CytoDyn / Leronlimab is there with the article... btw, all 19 companies/drugs have their write up dated 5/18/2020 (nicely done by Genetic Engineering and Biotechnology News or GEN).
https://www.genengnews.com/covid-19-candidates/cytodyn/
https://www.cytodyn.com/investors/news-events/in-the-news
I think CytoDyn added this above link, not only because it's fairly comprehensive in a summarized concise manner of recent events/news about the company but because at the bottom it states:
Quote:
COVID-19: 200 Candidates and Counting
To navigate through the >200 potential therapeutic and vaccine options for COVID-19, GEN has grouped the candidates into four broad categories based on their developmental and (where applicable) clinical progress:
So when you click on the "Front Runner" category, there are 19 out of 200 candidates and counting to address Covid-19:
https://www.genengnews.com/category/covid-19-...nt-runner/
And of course, CytoDyn / Leronlimab is there with the article... btw, all 19 companies/drugs have their write up dated 5/18/2020 (nicely done by Genetic Engineering and Biotechnology News or GEN).
(1)
(0)
